Chroman derivatives having estrogen receptor degradation activity and uses thereof
US11261178B2 · kind B2 · utility
5Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2020 |
| Grant date | Mar 1, 2022 |
| Priority date | — |
| Expiry date | Jun 22, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to novel compounds, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of cancer and related diseases and conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.